Table 6 Cluster detection analysis results for depression trajectory groups in Galveston and Chambers counties, TX, using the maximum reported spatial window of 40% of the sample population and the multivariate scan statistic.
From: Mapping concentrations of posttraumatic stress and depression trajectories following Hurricane Ike
LLR | Predictor group | Trajectory group | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Cluster 1** | Resilience | Delayed | Recovery | Chronic | ||||||
Radius | RR | % | RR | % | RR | % | RR | % | ||
3.4km | 45.61 | 55 years or older | 0.81 | 50.0 | 0.81 | 10.0 | 1.10 | 21.7 | 2.97 | 18.3 |
non-Hispanic Black | 0.46 | 29.0 | 5.03 | 29.0 | 0.84 | 16.1 | 2.24 | 25.8 | ||
4+ traumatic events before Hurricane Ike | 0.54 | 30.3 | 0.68 | 9.1 | 1.46 | 33.3 | 3.39 | 27.3 | ||
Predisaster probable PTSD | 0.32 | 14.3 | 0.80 | 7.1 | 0.75 | 21.4 | 3.20 | 57.1 | ||
Predisaster probable major depression | 0.37 | 17.9 | 1.17 | 14.3 | 1.16 | 32.1 | 2.92 | 35.7 | ||
Financial loss as a result of Ike | 0.80 | 40.0 | 0.50 | 7.30 | 1.07 | 25.5 | 2.36 | 27.3 | ||
Medium peri-event emotional reactions | 0.63 | 37.5 | 2.27 | 20.8 | 1.24 | 29.2 | 1.53 | 12.5 | ||
High peri-event emotional reactions | 0.32 | 14.3 | 1.41 | 17.9 | 0.61 | 17.9 | 3.59 | 50.0 | ||
Collective efficacy | 0.66 | 44.4 | 1.56 | 13.9 | 1.78 | 33.3 | 1.56 | 8.3 | ||
Cluster 2* | ||||||||||
2.7 km | 35.11 | 55 years or older | 1.76 | 100 | — | — | — | — | — | — |
non-Hispanic Black | 2.05 | 100 | — | — | — | — | — | — | ||
4+ traumatic events before Hurricane Ike | 1.78 | 85.7 | — | — | 0.27 | 7.1 | 0.60 | 7.1 | ||
Predisaster probable PTSD | 2.57 | 85.7 | — | — | — | — | 0.53 | 14.30 | ||
Predisaster probable major depression | 2.24 | 81.8 | — | — | 0.61 | 18.2 | — | — | ||
Financial loss as a result of Ike | 1.88 | 85.7 | — | — | 0.58 | 14.3 | — | — | ||
Medium peri-event emotional reactions | 1.04 | 57.1 | — | — | 1.17 | 28.6 | 1.64 | 14.3 | ||
High peri-event emotional reactions | 2.94 | 100 | — | — | — | — | — | — | ||
Collective efficacy | 1.45 | 98.5 | — | — | 0.49 | 10.5 | — | — |